WO2004032823A3 - Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte - Google Patents

Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte Download PDF

Info

Publication number
WO2004032823A3
WO2004032823A3 PCT/FR2003/050083 FR0350083W WO2004032823A3 WO 2004032823 A3 WO2004032823 A3 WO 2004032823A3 FR 0350083 W FR0350083 W FR 0350083W WO 2004032823 A3 WO2004032823 A3 WO 2004032823A3
Authority
WO
WIPO (PCT)
Prior art keywords
enteritis
adults
treatment
limit
side effects
Prior art date
Application number
PCT/FR2003/050083
Other languages
English (en)
Other versions
WO2004032823A8 (fr
WO2004032823A2 (fr
Inventor
Jack Auzerie
Original Assignee
Innovations Pharma Ag
Jack Auzerie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovations Pharma Ag, Jack Auzerie filed Critical Innovations Pharma Ag
Priority to AU2003292354A priority Critical patent/AU2003292354A1/en
Priority to EP03767923A priority patent/EP1553936A2/fr
Publication of WO2004032823A2 publication Critical patent/WO2004032823A2/fr
Publication of WO2004032823A3 publication Critical patent/WO2004032823A3/fr
Publication of WO2004032823A8 publication Critical patent/WO2004032823A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'objet de l'invention est une composition de traitement et de réhydratation pour limiter les effets secondaires tel que les sensations de malaise et de fatigue, au cours des gastro-entérites chez l'adulte, particulièrement chez les sujets âgés, comprenant un antiseptique intestinal tel que le nifuroxazide ou un modificateur du transit intestinal tel que le lopéramide ou encore des argiles, du glucose et du saccharose, caractérisée en ce que le rapport du glucose sur le saccharose est tel que l'osmolalité est comprise entre 260 et 290 mosm, en sorte de combiner efficacité et acceptabilité
PCT/FR2003/050083 2002-10-09 2003-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte WO2004032823A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003292354A AU2003292354A1 (en) 2002-10-09 2003-10-09 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults
EP03767923A EP1553936A2 (fr) 2002-10-09 2003-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l adulte

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/12544 2002-10-09
FR0212544A FR2845600B1 (fr) 2002-10-09 2002-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte

Publications (3)

Publication Number Publication Date
WO2004032823A2 WO2004032823A2 (fr) 2004-04-22
WO2004032823A3 true WO2004032823A3 (fr) 2004-12-23
WO2004032823A8 WO2004032823A8 (fr) 2005-05-06

Family

ID=32039576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/050083 WO2004032823A2 (fr) 2002-10-09 2003-10-09 Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte

Country Status (4)

Country Link
EP (1) EP1553936A2 (fr)
AU (1) AU2003292354A1 (fr)
FR (1) FR2845600B1 (fr)
WO (1) WO2004032823A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2446797C1 (ru) * 2011-02-24 2012-04-10 Петр Леонидович Щербаков Способ лечения кислотозависимых состояний, ассоциированных с хеликобактер пилори
ITRM20120341A1 (it) 2012-07-17 2014-01-18 Er La Salute Della Donna E Del Bambino Soluzione glucosalina di mantenimento per la somministrazione parenterale ad uso pediatrico

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558061A1 (fr) * 1983-12-27 1985-07-19 Auzerie Jack Composition pour solutions de rehydratation par voie orale des nourrissons et solutions la contenant
US4942042A (en) * 1985-05-15 1990-07-17 Societe De Conseils De Recherches Et D'applications Scientifiques (S. C. A. S.) Anti-diarrhea compositions
EP0393909A1 (fr) * 1989-04-13 1990-10-24 Beecham Group p.l.c. Composition
EP0482580A1 (fr) * 1990-10-24 1992-04-29 Ss Pharmaceutical Co., Ltd. Compositions antidiarrhéiques
EP0919239A1 (fr) * 1997-11-12 1999-06-02 Investigations therapeutiques essais cliniques services société à Responsabilité Limitée Composition pour le traitement des gastro-entérites aigues, comprenant une solution de réhydratation avec un composé à action synérgique

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558061A1 (fr) * 1983-12-27 1985-07-19 Auzerie Jack Composition pour solutions de rehydratation par voie orale des nourrissons et solutions la contenant
US4942042A (en) * 1985-05-15 1990-07-17 Societe De Conseils De Recherches Et D'applications Scientifiques (S. C. A. S.) Anti-diarrhea compositions
EP0393909A1 (fr) * 1989-04-13 1990-10-24 Beecham Group p.l.c. Composition
EP0482580A1 (fr) * 1990-10-24 1992-04-29 Ss Pharmaceutical Co., Ltd. Compositions antidiarrhéiques
EP0919239A1 (fr) * 1997-11-12 1999-06-02 Investigations therapeutiques essais cliniques services société à Responsabilité Limitée Composition pour le traitement des gastro-entérites aigues, comprenant une solution de réhydratation avec un composé à action synérgique

Also Published As

Publication number Publication date
EP1553936A2 (fr) 2005-07-20
FR2845600B1 (fr) 2005-07-08
AU2003292354A8 (en) 2004-05-04
WO2004032823A8 (fr) 2005-05-06
WO2004032823A2 (fr) 2004-04-22
FR2845600A1 (fr) 2004-04-16
AU2003292354A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
NO20024011L (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
EP2305269A3 (fr) Oligosaccharides immunomodulateurs
AU2002358348A8 (en) Soft drink replacer
AU2001276952A1 (en) Method of treating the syndrome of coronary heart disease risk factors in humans
WO2005016300A3 (fr) Lingette et procedes d'amelioration de la sante dermatologique
ATE336181T1 (de) Entbittertes zitrusfruchtmark und verfahren zur herstellung
EP1994913A3 (fr) Dispositif de fixation et d'ancrage de prothèses de valvule
DK1481682T3 (da) Præparat som indeholder oligosaccharider og probiotika
NO20045588L (no) Probiotiske midler og oral toleranse
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
EP1393734A4 (fr) Medicaments pour les maladies intestinales
WO2001032160A3 (fr) Modification de la concentration de cholesterol au moyen de substances phytochimiques d'agrumes
TNSN06199A1 (en) Shape-adapted absorbent article with improved absorption capacity
CA2412789A1 (fr) Compositions destinees a ameliorer la concentration mentale
WO2004032823A3 (fr) Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
CA2534483A1 (fr) Composition et methode de traitement du bezoard et du trichobezoard
AR013274A1 (es) Producto de cereal cocido enriquecido, organolepticamente aceptable para consumo humano.
ITMI20001323A0 (it) Apparecchiatura per la realizzazione di fresature in travi di legno, per l'inserimento di putrelle e simili.
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease
EP1245156A3 (fr) Systèmes anhydrés comestibles et basés sur lipides
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.
AU2002315139A1 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
KR950026522A (ko) 베타-카로틴을 함유하는 두통 예방 및 치료제 조성물
WO2002074333A3 (fr) Agent immunotherapeutique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003767923

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 17/2004 ADD "DECLARATION UNDER RULE 4.17: AS TO THE APPLICANT S ENTITLEMENT TO CLAIMTHE PRIORITY OF THE EARLIER APPLICATION (RULE 4.17(III)) FOR ALL DESIGNATED STATES"

WWP Wipo information: published in national office

Ref document number: 2003767923

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP